Correction: CYFIP1 coordinate with RNMT to induce osteosarcoma cuproptosis via AURKAIP1 m7G modification
Zili Lin, Ziyi Wu, Yizhe He, Xiangyao Li, Wei Luo
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 3
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsRNA modifications and cancer · MicroRNA in disease regulation · interferon and immune responses
Correction **: ** **Molecular Medicine (2025) 31:74 ** 10.1186/s10020-025-01127-3
In this article (Lin et al. 2025), Fig. 3 appeared incorrectly and have now been corrected in the original publication. For completeness and transparency, both incorrect and correct versions are displayed below.
The original article has been corrected.
Incorrect Fig. 3
Correct Fig. 3Fig. 3. Validation of the role of CYFIP1 via downregulation experiment. A–D WB and qPCR exhibited the knockdown efficiency of shRNA transfection. E, F Knockdown of CYFIP1 promoted osteosarcoma cells migration. G Knockdown of CYFIP1 decreased osteosarcoma cells apoptosis. H–J CCK8 and EdU assays exhibited knockdown of CYFIP1 promoted osteosarcoma cells proliferation. The data represent the mean ± S.D. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 indicates a significant difference between the indicated groups